Novartis appeals the decision of Pumfrey J, [2006] EWHC 2506 (Pat) that Ivax’s ‘Equoral’ product does not infringe its UK patent No. 2,222,770 (the ‘Patent’). The Judge held the patent valid.
Judges:
Buxton LJ, Jacob LJ, Hughes LJ
Citations:
[2007] EWCA Civ 971
Links:
Jurisdiction:
England and Wales
Citing:
Appeal from – Novartis Ag v Ivax Pharmaceuticals UK Ltd PatC 16-Oct-2006
Patents – action for infringement of two patents relating to the formulation of cyclosporin, which is a pharmaceutical of particular utility in producing immunosuppression in recipients of allogenic organ transplants. . .
Lists of cited by and citing cases may be incomplete.
Intellectual Property
Updated: 12 July 2022; Ref: scu.259918